Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionNwam Llc
Latest Disclosed Ownership12,940 shares
Latest Disclosed Value $ 1,803,435
Nwam Llc reports 2.26% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 4, 2026 - Nwam Llc filed a 13F-HR form disclosing ownership of 12,940 shares of Gilead Sciences, Inc. (US:GILD) valued at $1,803,448 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 13,239 shares of Gilead Sciences, Inc.. This represents a change in shares of -2.26% during the quarter. The current value of the position is $1,669,131 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F GILEAD SCIENCES COM 375558103 12,940 -299 -2.26 1,803 0.33 0.1038
2026-02-04 2025-12-31 13F GILEAD SCIENCES COM 375558103 13,239 -935 -6.60 1,797 4.29 0.1004
2026-02-04 2025-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 14,174 -931 -6.16 1,723 1.77 0.0935
2025-10-28 2025-09-30 13F GILEAD SCIENCES COM 375558103 14,174 867 1,703 0.1197
2026-02-04 2025-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 15,105 -59 -0.39 1,694 -0.35 0.0984
2025-08-07 2025-06-30 13F GILEAD SCIENCES COM 375558103 13,307 -1,857 1,527 0.1243
2025-05-05 2025-03-31 13F GILEAD SCIENCES COM 375558103 15,164 -1,325 -8.04 1,699 11.56 0.1461
2025-02-05 2024-12-31 13F GILEAD SCIENCES COM 375558103 16,489 -13 -0.08 1,523 10.12 0.0942
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 16,502 -84 -0.51 1,384 21.64 0.0844
2024-07-24 2024-06-30 13F GILEAD SCIENCES COM 375558103 16,586 557 3.47 1,138 6.86 0.3344
2024-05-09 2024-03-31 13F GILEAD SCIENCES COM 375558103 16,029 -1,183 -6.87 1,065 -23.67 0.0860
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 17,212 1,490 9.48 1,394 18.34 0.1120
2023-11-01 2023-09-30 13F GILEAD SCIENCES COM 375558103 15,722 -2,098 -11.77 1,178 -14.20 0.1195
2023-08-10 2023-06-30 13F GILEAD SCIENCES COM 375558103 17,820 -1,002 -5.32 1,373 -12.04 0.1128
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 18,822 -159 -0.84 1,562 -4.17 0.1584
2023-02-08 2022-12-31 13F GILEAD SCIENCES COM 375558103 18,981 1,306 7.39 1,630 49.45 0.1444
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 17,675 -1,003 -5.37 1,090 -6.36 0.1040
2022-08-10 2022-06-30 13F GILEAD SCIENCES COM 375558103 18,678 -1,690 -8.30 1,164 -3.88 0.1075
2022-05-12 2022-03-31 13F GILEAD SCIENCES COM 375558103 20,368 -3,825 -15.81 1,211 -31.08 0.0930
2022-02-10 2021-12-31 13F GILEAD SCIENCES COM 375558103 24,193 8,340 52.61 1,757 58.72 0.1389
2021-11-03 2021-09-30 13F GILEAD SCIENCES COM 375558103 15,853 2,508 18.79 1,107 20.46 0.1004
2021-08-04 2021-06-30 13F GILEAD SCIENCES COM 375558103 13,345 308 2.36 919 9.02 0.0853
2021-04-23 2021-03-31 13F GILEAD SCIENCES COM 375558103 13,037 1,990 18.01 843 30.90 0.0839
2021-01-22 2020-12-31 13F GILEAD SCIENCES COM 375558103 11,047 -2,016 -15.43 644 -21.94 0.0735
2020-10-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 13,063 -4,382 -25.12 825 -38.52 0.1361
2020-07-21 2020-06-30 13F GILEAD SCIENCES COM 375558103 17,445 219 1.27 1,342 4.19 0.1879
2020-04-16 2020-03-31 13F GILEAD SCIENCES COM 375558103 17,226 1,864 12.13 1,288 29.06 0.0348
2020-01-23 2019-12-31 13F GILEAD SCIENCES COM 375558103 15,362 1,800 13.27 998 16.05 0.1726
2019-10-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 13,562 629 4.86 860 -1.60 0.1609
2019-07-18 2019-06-30 13F GILEAD SCIENCES COM 375558103 12,933 900 7.48 874 11.76 0.1740
2019-04-17 2019-03-31 13F GILEAD SCIENCES COM 375558103 12,033 -1,206 -9.11 782 -5.56 0.1687
2019-01-30 2018-12-31 13F GILEAD SCIENCES COM 375558103 13,239 -601 -4.34 828 -22.54 0.2127
2018-10-09 2018-09-30 13F GILEAD SCIENCES COM 375558103 13,840 184 1.35 1,069 10.55 0.2403
2018-07-25 2018-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 13,656 -205 -1.48 967 -7.46 0.2290
2018-07-16 2018-06-30 13F GILEAD SCIENCES COM 375558103 13,656 -205 967 0.0792
2018-04-16 2018-03-31 13F GILEAD SCIENCES COM 375558103 13,861 -353 -2.48 1,045 2.65 0.2640
2018-02-07 2017-12-31 13F GILEAD SCIENCES COM 375558103 14,214 -2,283 -13.84 1,018 -23.86 0.2578
2017-11-01 2017-09-30 13F GILEAD SCIENCES COM 375558103 16,497 3,477 26.71 1,337 45.01 0.3475
2017-07-27 2017-06-30 13F GILEAD SCIENCES COM 375558103 13,020 616 4.97 922 9.50 0.1604
2017-05-01 2017-03-31 13F GILEAD SCIENCES COM 375558103 12,404 1,084 9.58 842 3.82 0.2569
2017-02-02 2016-12-31 13F GILEAD SCIENCES COM 375558103 11,320 974 9.41 811 -0.98 0.2690
2016-10-26 2016-09-30 13F GILEAD SCIENCES COM 375558103 10,346 -109 -1.04 819 -6.08 0.0621
2016-08-04 2016-06-30 13F GILEAD SCIENCES COM 375558103 10,455 -1,660 -13.70 872 -21.65 0.3426
2016-05-16 2016-03-31 13F GILEAD SCIENCES COM 375558103 12,115 -386 -3.09 1,113 -12.02 0.4410
2016-02-12 2015-12-31 13F GILEAD SCIENCES COM 375558103 12,501 501 4.17 1,265 5.59 0.5161
2015-11-17 2015-09-30 13F GILEAD SCIENCES COM 375558103 12,000 1,000 9.09 1,198 -9.86 0.9938
2015-10-15 2015-06-30 13F GILEAD SCIENCES COM 375558103 11,000 -104 -0.94 1,329 21.93 0.5559
2016-09-08 2015-03-31 13F GILEAD SCIENCES COM 375558103 11,104 2,654 31.41 1,090 36.93 0.4660
2016-09-08 2014-12-31 13F GILEAD SCIENCES COM 375558103 8,450 2,227 35.79 796 20.24 0.3476
2016-09-08 2014-09-30 13F GILEAD SCIENCES COM 375558103 6,223 -152 -2.38 662 25.14 0.2357
2016-09-08 2014-06-30 13F GILEAD SCIENCES COM 375558103 6,375 1,012 18.87 529 39.21 0.1646
2016-09-08 2014-03-31 13F GILEAD SCIENCES COM 375558103 5,363 5,363 0.00 380 0.1307
2016-09-08 2013-12-31 13F GILEAD SCIENCES COM 375558103 0 -3,494 -100.00 0 -100.00
2016-09-08 2013-09-30 13F GILEAD SCIENCES COM 375558103 3,494 -791 -18.46 220 0.00 0.1069
2016-09-08 2013-06-30 13F GILEAD SCIENCES COM 375558103 4,285 -204 -4.54 220 0.00 0.1112
2016-09-08 2013-03-31 13F GILEAD SCIENCES COM 375558103 4,489 -1,224 -21.42 220 -47.62 0.1081
2016-09-08 2012-12-31 13F GILEAD SCIENCES COM 375558103 5,713 -613 -9.69 420 0.00 0.1776
2016-09-08 2012-09-30 13F GILEAD SCIENCES COM 375558103 6,326 1,410 28.68 420 66.67 0.1764
2016-09-08 2012-06-30 13F GILEAD SCIENCES COM 375558103 4,916 4,916 252 0.1167
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.